Home Cart 0 Sign in  
X

[ CAS No. 59227-89-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 59227-89-3
Chemical Structure| 59227-89-3
Chemical Structure| 59227-89-3
Structure of 59227-89-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 59227-89-3 ]

Related Doc. of [ 59227-89-3 ]

Alternatived Products of [ 59227-89-3 ]

Product Details of [ 59227-89-3 ]

CAS No. :59227-89-3 MDL No. :MFCD00190580
Formula : C18H35NO Boiling Point : -
Linear Structure Formula :- InChI Key :AXTGDCSMTYGJND-UHFFFAOYSA-N
M.W : 281.48 Pubchem ID :42981
Synonyms :
Chemical Name :1-Dodecylazepan-2-one

Calculated chemistry of [ 59227-89-3 ]

Physicochemical Properties

Num. heavy atoms : 20
Num. arom. heavy atoms : 0
Fraction Csp3 : 0.94
Num. rotatable bonds : 11
Num. H-bond acceptors : 1.0
Num. H-bond donors : 0.0
Molar Refractivity : 93.54
TPSA : 20.31 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : Yes
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -4.53 cm/s

Lipophilicity

Log Po/w (iLOGP) : 4.25
Log Po/w (XLOGP3) : 4.91
Log Po/w (WLOGP) : 4.93
Log Po/w (MLOGP) : 3.88
Log Po/w (SILICOS-IT) : 5.39
Consensus Log Po/w : 4.67

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 1.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.95
Solubility : 0.0314 mg/ml ; 0.000112 mol/l
Class : Soluble
Log S (Ali) : -5.07
Solubility : 0.00238 mg/ml ; 0.00000846 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -5.61
Solubility : 0.000693 mg/ml ; 0.00000246 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 2.32

Safety of [ 59227-89-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P264-P270-P271-P280-P301+P312+P330-P302+P352-P304+P340+P312-P305+P351+P338-P332+P313-P337+P313-P362-P403+P233-P405-P501 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 59227-89-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 59227-89-3 ]
  • Downstream synthetic route of [ 59227-89-3 ]

[ 59227-89-3 ] Synthesis Path-Upstream   1~9

  • 1
  • [ 105-60-2 ]
  • [ 143-15-7 ]
  • [ 59227-89-3 ]
YieldReaction ConditionsOperation in experiment
99.6% With sodium hydroxide In water; toluene EXAMPLE 1
A 1l reactor is charged with 34 g (0.3 mole) of azacycloheptane-2-one, 112 g (0.45 mole) of dodecyl bromide, 300 g of toluene, 3.4 g (3.3 mole percent based on the azacycloheptane-2-one) of crystalline tetrabutylammonium hydrogensulfate (TBAHS) and 90 g (2.25 moles) of flaky sodium hydroxide.
This heterogeneous mixture was stirred at 50° C. for 10 hours.
After the mixture was cooled to 40° C., 135 g of water was added to the mixture, followed by stirring at 40° C. for 30 minutes.
The oil layer was separated and the oil layer thus obtained was subjected to distillation, giving 84.0 g of 1-dodecylazacycloheptane-2-one having a boiling point of 195° to 200° C./3 mmHg (yield of 99.6percent based on the azacycloheptane-2-one), and also 0.8 g of dodecyl ether (yield of 1.0percent based on the dodecyl bromide).
95% With sodium hydroxide In toluene EXAMPLE 3
A 1l reactor was charged with 57 g (0.5 mole) of azacycloheptane-2-one, 125 g (0.5 mole) of dodecyl bromide, 182 g of toluene, 3.2 g (2 mole percent) of crystalline tetrabutylammonium bromide (TBAB) and 60 g (1.5 moles) of flaky sodium hydroxide.
This heterogeneous mixture was stirred at 50° C. for 10 hours.
The same aftertreatment as in Example 1 was repeated, giving 133.5 g of 1-dodecylazacycloheptane-2-one (yield of 95.0percent) and 0.7 g of dodecyl ether (yield of 0.8percent)
92.8% With sodium hydroxide; tetrabutylammomium bromide; potassium carbonate In cyclohexane EXAMPLE 1
Preparation of 1-n-dodecylazacycloheptan-2-one at a bath temperature of 55° C.
117 g of caprolactam (1.033 mole), 10 g of tetrabutylammonium bromide (0.03 mole), 100 g of anhydrous potassium carbonate (0.7 mole, dried for 2 hrs at 120 C.), 100 g of pulverized sodium hydroxide (2.5 mole), and 1 L of cyclohexane were placed in a flask equipped with a funnel, reflux condenser and a mechanical stirrer.
To this mixture were added dropwise a solution of 250 ml of 1-bromododecane (1.033 mole) and 250 ml of cyclohexane with vigorous stirring over one-half hour at a bath temperature of 55° C.
The stirring was continued; in the meanwhile thin-layer chromatography was used to monitor the course of the reaction, and it was found that the reaction was completed after 7 hours.
The reaction mixture was then cooled to room temperature and filtered.
The filtrate was washed with water (3*500 ml) to remove remaining caprolactam.
The organic phase was dried over anhydrous magnesium sulfate.
The filtrate was evaporated using a rotary film evaporator to remove cyclohexane (which can be used again), and the residue was distilled at reduced pressure to yield 270 g of colorless, odorless, transparent liquid product (yield: 92.8percent), b,p.200-201 C/0.7 mmHg.
Reference: [1] Patent: US4812566, 1989, A,
[2] Patent: US4812566, 1989, A,
[3] Patent: US4973688, 1990, A,
[4] JAOCS, Journal of the American Oil Chemists' Society, 1996, vol. 73, # 7, p. 847 - 850
[5] Journal of Pharmaceutical Sciences, 1993, vol. 82, # 2, p. 214 - 219
[6] Journal of Pharmaceutical Sciences, 1989, vol. 78, # 9, p. 738 - 741
  • 2
  • [ 143-15-7 ]
  • [ 59227-89-3 ]
Reference: [1] Patent: US4422970, 1983, A,
  • 3
  • [ 112-52-7 ]
  • [ 59227-89-3 ]
Reference: [1] Patent: US4812566, 1989, A,
  • 4
  • [ 143-15-7 ]
  • [ 3553-94-4 ]
  • [ 59227-89-3 ]
Reference: [1] Patent: US4692523, 1987, A,
  • 5
  • [ 105-60-2 ]
  • [ 143-15-7 ]
  • [ 59227-89-3 ]
Reference: [1] Patent: US4310525, 1982, A,
  • 6
  • [ 105-60-2 ]
  • [ 1634-04-4 ]
  • [ 143-15-7 ]
  • [ 59227-89-3 ]
Reference: [1] Patent: US5986092, 1999, A,
  • 7
  • [ 105-60-2 ]
  • [ 143-15-7 ]
  • [ 59227-89-3 ]
Reference: [1] Patent: US4525199, 1985, A,
  • 8
  • [ 112-53-8 ]
  • [ 59227-89-3 ]
Reference: [1] JAOCS, Journal of the American Oil Chemists' Society, 1996, vol. 73, # 7, p. 847 - 850
  • 9
  • [ 105-60-2 ]
  • [ 59227-89-3 ]
Reference: [1] Journal of Organic Chemistry, 1953, vol. 18, p. 1087,1088
Same Skeleton Products
Historical Records